Terms: = Ovarian cancer AND CEACAM5, CEA AND Diagnosis
266 results:
1. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
2. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract] [Full Text] [Related]
3. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
4. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
5. [A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
Ishii M; Yamamoto Y; Yoshimura A; Hayashi T; Kawamura N; Nagahara A; Nakai Y; Nakayama M; Nishimura K
Hinyokika Kiyo; 2023 Apr; 69(4):107-112. PubMed ID: 37183041
[TBL] [Abstract] [Full Text] [Related]
6. ovarian strumal carcinoid: a case report.
Kanasugi M; Nishiyama H; Sanpei M; Asano S; Honda T
Fukushima J Med Sci; 2023 Apr; 69(1):51-55. PubMed ID: 36878591
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic Features and the Loss of ARID1A Expression in ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
8. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
9. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors.
Kobayashi H; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kimura F
J Obstet Gynaecol Res; 2022 Sep; 48(9):2442-2451. PubMed ID: 35778814
[TBL] [Abstract] [Full Text] [Related]
10. Giant ovarian tumor with colorectal cancer: suggestion concerning the need for colonoscopy screening in cases with large ovarian tumor-a report of three cases.
Maeda Y; Minagawa N; Shoji H; Kobayashi T; Yamamoto K
BMC Surg; 2022 Mar; 22(1):111. PubMed ID: 35321695
[TBL] [Abstract] [Full Text] [Related]
11. Engineering a G-quadruplex-based logic gate platform for sensitive assay of dual biomarkers of ovarian cancer.
Li M; Yao B; Jing C; Chen H; Zhang Y; Zhou N
Anal Chim Acta; 2022 Mar; 1198():339559. PubMed ID: 35190125
[TBL] [Abstract] [Full Text] [Related]
12. BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy.
Abdelrazek MA; Nageb A; Barakat LA; Abouzid A; Elbaz R
Breast Cancer; 2022 May; 29(3):507-515. PubMed ID: 34994942
[TBL] [Abstract] [Full Text] [Related]
13. Photonic crystal barcodes assembled from dendritic silica nanoparticles for the multiplex immunoassays of ovarian cancer biomarkers.
Ji DD; Wu MX; Ding SN
Anal Methods; 2022 Jan; 14(3):298-305. PubMed ID: 34985054
[TBL] [Abstract] [Full Text] [Related]
14. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
[TBL] [Abstract] [Full Text] [Related]
15. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
16. A radiomic nomogram based on arterial phase of CT for differential diagnosis of ovarian cancer.
Hu Y; Weng Q; Xia H; Chen T; Kong C; Chen W; Pang P; Xu M; Lu C; Ji J
Abdom Radiol (NY); 2021 Jun; 46(6):2384-2392. PubMed ID: 34086094
[TBL] [Abstract] [Full Text] [Related]
17. Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
Onda T; Tanaka YO; Kitai S; Manabe T; Ishikawa M; Hasumi Y; Miyamoto K; Ogawa G; Satoh T; Saito T; Kasamatsu T; Nakanishi T;
Jpn J Clin Oncol; 2021 Feb; 51(2):205-212. PubMed ID: 33556170
[TBL] [Abstract] [Full Text] [Related]
18. Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.
Ohya A; Ichinohe F; Matoba H; Kobara H; Fujinaga Y
Abdom Radiol (NY); 2021 Jun; 46(6):2393-2402. PubMed ID: 33388806
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative Differentiation of Benign and Malignant Non-epithelial ovarian Tumors: Clinical Features and Tumor Markers.
Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
[TBL] [Abstract] [Full Text] [Related]
20. Institutional results of Oncoovarian Dx - a novel algorithm for the preoperative evaluation of adnexal masses.
Kubelac P; Craciun A; Jalba O; Gheorghe S; Lazar G; Ignat F; Lisencu C; Rancea A; Vlad C; Irimie A; Achimas Cadariu P
J BUON; 2020; 25(3):1658-1663. PubMed ID: 32862619
[TBL] [Abstract] [Full Text] [Related]
[Next]
